| Literature DB >> 31611352 |
Liyuan Wang1, Dejun Liu2, Yuan Lv3, Lanqing Cui1, Yun Li1, Tianmeng Li1, Huangwei Song2, Yuxin Hao2, Jianzhong Shen2, Yang Wang2, Timothy R Walsh4,5.
Abstract
A novel, plasmid-mediated, high-level tigecycline resistance tet(X) gene variant, tet(X5), was detected in a clinical Acinetobacter baumannii isolate from China in 2017. Tet(X5) shows 84.5% and 90.5% amino acid identity to Tet(X3) and Tet(X4), respectively, with similar binding sites and a comparable affinity for tetracyclines. The tet(X5)-containing plasmid could only be transferred to A. baumannii via electrotransformation. This report follows the recent study describing the identification of tet(X3) and tet(X4).Entities:
Keywords: Acinetobacter baumanniizzm321990; tet(X5); tigecycline
Mesh:
Substances:
Year: 2019 PMID: 31611352 PMCID: PMC7187588 DOI: 10.1128/AAC.01326-19
Source DB: PubMed Journal: Antimicrob Agents Chemother ISSN: 0066-4804 Impact factor: 5.191